Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results

被引：1
|
作者：
Nasnas, Patrice [1 ]
Jabbour, Elias [1 ]
Short, Nicholas [1 ]
Sasaki, Koji [1 ]
Ravandi, Farhad [1 ]
Jain, Nitin [2 ]
Daver, Naval [1 ]
Pemmaraju, Naveen [1 ]
Yilmaz, Musa [2 ]
Kadia, Tapan M. [2 ]
Garris, Rebecca [1 ]
Garcia-Manero, Guillermo [1 ]
DiNardo, Courtney D. [1 ]
Konopleva, Marina [3 ]
Wierda, William G. [4 ]
Kwari, Monica [1 ]
Loiselle, Christopher [1 ]
Milton, Anna [1 ]
Rivera, Juan [1 ]
Banks, Glenda [1 ]
Kantarjian, Hagop [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[3] MD Anderson Canc Ctr, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167761
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3250 / 3252
页数：3
相关论文
共 50 条
  • [41] Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitor
    Basile, Gaetan
    Galtier, Jean
    Cazaubiel, Titouan
    Forcade, Edouard
    Klein, Emilie
    Bidet, Audrey
    Botella-Garcia, Carmen
    Mediavilla, Clemence
    Clement, Laurence
    Dumas, Pierre-Yves
    Pigneux, Arnaud
    Leguay, Thibaut
    EJHAEM, 2025, 6 (01):
  • [42] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Ribera, Josep-Maria
    Prawitz, Thibaud
    Freitag, Andreas
    Sharma, Anuj
    Dobi, Balazs
    Rizzo, Federica
    Sabatelli, Lorenzo
    Patos, Petros
    ADVANCES IN THERAPY, 2023, 40 (07) : 3087 - 3103
  • [43] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Josep-Maria Ribera
    Thibaud Prawitz
    Andreas Freitag
    Anuj Sharma
    Balázs Dobi
    Federica Rizzo
    Lorenzo Sabatelli
    Petros Patos
    Advances in Therapy, 2023, 40 : 3087 - 3103
  • [44] The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia
    Wu, Xiaoxia
    Lu, Shenqi
    Zhang, Xinhui
    Yang, Zhen
    Sun, Aining
    Wu, Depei
    Zhou, Huifen
    Miao, Miao
    CANCER MEDICINE, 2024, 13 (17):
  • [45] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Couturier, Marie-Anne
    Thomas, Xavier
    Raffoux, Emmanuel
    Huguet, Francoise
    Berthon, Celine
    Simand, Celestine
    Gallego-Hernanz, Maria-Pilar
    Hicheri, Yosr
    Berger, Mathilde Hunault
    Saillard, Colombe
    Leguay, Thibaut
    Loiseau, Clemence
    Bene, Marie-Christine
    Chevallier, Patrice
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
  • [46] Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?
    Thomas, Xavier
    BULLETIN DU CANCER, 2011, 98 (07) : 761 - 767
  • [47] Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Lim, Sung-Nam
    Lee, Kyoo-Hyung
    Kim, Dae-Young
    Lee, Je-Hwan
    Lee, Jung-Hee
    Chi, Hyun-Sook
    Joo, Young-Don
    Lee, Won Sik
    Lee, Sang Min
    Park, Seonyang
    Kim, Inho
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Kim, Min Kyoung
    Yang, Deok-Hwan
    Eom, Hyeon-Seok
    Lee, Gyeong-Won
    Jung, Chul Won
    Won, Jong-Ho
    Kim, Hawk
    Lee, Jae-Hoon
    Shin, Ho-Jin
    Kim, Ho Young
    Hyun, Myung Soo
    Kim, Hyeoung Joon
    BLOOD, 2014, 124 (21)
  • [48] Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia
    Yilmaz, Musa
    Kantarjian, Hagop
    Ravandi, Farhad
    Thomas, Deborah
    Khouri, Maria
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Cortes, Jorge
    Short, Nicholas
    Sasaki, Koji
    Issa, Ghayas
    Koller, Paul
    Schroeder, Heather
    Kadia, Tapan
    Verstovsek, Srdan
    Daver, Naval
    Jain, Nitin
    Konopleva, Marina
    O'Brien, Susan
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S185 - S185
  • [49] Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy
    Ohno R.
    Current Hematologic Malignancy Reports, 2006, 1 (3) : 180 - 187
  • [50] Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
    Sasaki, Koji
    Koller, Paul B.
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Khouri, Maria R.
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Cortes, Jorge E.
    Schroeder, Heather
    Chahoud, Jad
    Kadia, Tapan
    Ravandi, Farhad
    Verstovsek, Srdan
    Daver, Naval
    Jain, Nitin
    Konopleva, Marina
    O'Brien, Susan
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
12345